Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 80 of 2838 for:    Neoplasms, Germ Cell and Embryonal | Neuroendocrine Tumors

Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors. (ATLANT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02698410
Recruitment Status : Completed
First Posted : March 3, 2016
Last Update Posted : July 26, 2019
Sponsor:
Information provided by (Responsible Party):
Ipsen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 8, 2019
Actual Study Completion Date : June 18, 2019